Fangfang Z. Yang

No.59 Haier Road
Qingdao, 266000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Preparation and mechanism of heterogeneous MX@MIL-125(Ti) towards sonodynamic therapy.

Preparation and mechanism of heterogeneous MX@MIL-125(Ti) towards sonodynamic therapy.

Journal: Colloids and surfaces. B, Biointerfaces

Published: April 04, 2026

SMARCA4 deficiency contributes to platinum resistance in non-small cell lung cancer by activating the NF-κB-BIRC2/BIRC3 signaling axis.

SMARCA4 deficiency contributes to platinum resistance in non-small cell lung cancer by activating the NF-κB-BIRC2/BIRC3 signaling axis.

Journal: Journal of thoracic disease

Published: March 09, 2026

Breaking epigenetic shackles: targeting ARID1A methylation and the PI3K/AKT/mTOR-PD-L1 axis to overcome immune escape in gastric cancer.

Breaking epigenetic shackles: targeting ARID1A methylation and the PI3K/AKT/mTOR-PD-L1 axis to overcome immune escape in gastric cancer.

Journal: PeerJ

Published: May 28, 2025

ARID1A regulates colorectal cancer metastasis through the AKT/mTOR/p70S6K pathway.

ARID1A regulates colorectal cancer metastasis through the AKT/mTOR/p70S6K pathway.

Journal: Translational oncology

Published: May 26, 2025

Integrative analysis of fatty acid metabolism and identification of ANLN as a novel prognostic marker in lung adenocarcinoma.

Integrative analysis of fatty acid metabolism and identification of ANLN as a novel prognostic marker in lung adenocarcinoma.

Journal: Journal of thoracic disease

Published: April 26, 2025

ARID1A deficiency attenuates the response to EGFR-TKI treatment in lung adenocarcinoma.

ARID1A deficiency attenuates the response to EGFR-TKI treatment in lung adenocarcinoma.

Journal: Frontiers in pharmacology

Published: February 23, 2025

Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model.

Combination therapy with Chicoric acid and PD-1/PD-L1 blockade improves the immunotherapy response in patient-derived ovarian cancer xenograft model.

Journal: Cell communication and signaling : CCS

Published: December 16, 2024

Integrative analysis of ferroptosis in the hypoxic microenvironment of gastric cancer unveils the immune landscape and personalized therapeutic strategies.

Integrative analysis of ferroptosis in the hypoxic microenvironment of gastric cancer unveils the immune landscape and personalized therapeutic strategies.

Journal: Frontiers in oncology

Published: September 21, 2024

Metal-Organic Frameworks (MOF)-Assisted Sonodynamic Therapy in Anticancer Applications.

Metal-Organic Frameworks (MOF)-Assisted Sonodynamic Therapy in Anticancer Applications.

Journal: ACS nano

Published: February 21, 2023

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment.

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment.

Journal: Frontiers in oncology

Published: January 16, 2023

The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.

The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.

Journal: International journal of molecular sciences

Published: July 21, 2022

Characterization of glucose metabolism in breast cancer to guide clinical therapy.

Characterization of glucose metabolism in breast cancer to guide clinical therapy.

Journal: Frontiers in surgery

Published: June 20, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026